COPD and Asthma Diagnostic and Monitoring Devices Market: Current Analysis and Forecast (2021-2027)

$3500$6860

Emphasis on Therapeutic Devices (Ventilator, Mask, PAP (Positive airway pressure) Device, Inhaler, Nebulizer), Monitoring Devices (Pulse Oximeters, Capnography, Gas Analyzers); Diagnostic Devices (Spirometers, Polysomnography (PSG) Devices, Peak Flow Meters, Other Diagnostic Devices); Indication (Asthma, COPD); End-User (Hospitals, Clinics, Homecare, and Others); and Region & Country.

Pages:

208

Table:

53

Figure:

87

Report ID:

UMHE21249

Geography:

Clear
  Get a Free Sample
SKU: UMHE21249 Category:
Report Description
Table of content
Research Methodology

Report Description

Asthma and Chronic obstructive pulmonary disease (COPD) devices are mainly used as rescue therapy for diseases related to respiration. Asthma and COPD both show similar kinds of symptoms such as wheezing, coughing, and shortness of breath. However, COPD generally outlines progressive respiratory diseases such as chronic bronchitis and emphysema. Moreover, there are decreased levels of respiratory airflow and the inflammation of airway tissues in the case of COPD. According to the National Institutes of Health (NIH), more than 16 million Americans are suffering from the chronic obstructive pulmonary disease (COPD).

The demand for COPD and Asthma Diagnostic and Monitoring Devices is increasing on account of the rising incidence of Asthma and COPD cases, rise in the aging population, rising prevalence of tobacco smoking, increase in Urbanization and pollution, increase in the preterm birth cases, and lifestyle changes. Furthermore, the increase in government initiatives and the increase in focus of pharmaceutical companies to manufacture an advanced and portable inhalation device also drive the market growth.

Value Chain of Global COPD and Asthma Diagnostic and Monitoring Devices Market

Insights Presented in the Report

“Amongst Therapeutic devices, Inhaler segment holds the major share.”

Based on Therapeutic devices, the market is fragmented into Ventilator, Mask, PAP (Positive airway pressure) Device, Inhaler, and Nebulizer. Inhalers segment is expected to dominate the market in the upcoming period owing to no need for patient coordination, and ease to use. Inhalers are generally of two types metered-dose inhalers (MDIs) and dry-powder inhalers (DPIs). MDI provides slow deep inhalation and is propellant based while DPI provides rapid deep inhalation and is non-propellant-based. For instance, German Remedies launched “Novolizer” is a (DPI) approved for use with salbutamol (albuterol) and budesonide, for the treatment of Asthma and COPD attacks.

“Amongst Monitoring devices, pulse oximeters is anticipated to grow at the highest CAGR during the analyzed period.”

Based on Monitoring devices, the market is segmented into Pulse Oximeters, Capnography, and Gas Analyzers. The pulse oximeters segment is expected to dominate the market owing to its fast and accurate results. Furthermore, the rising awareness regarding the applications of a pulse oximeter in Covid-19 management and the high prevalence of respiratory diseases also propels the market growth. As per Worldometer (May 2021), there are around 22,992,517 covid-19 cases in India which demand pulse oximeter devices.

Amongst Diagnostic devices, the Peak Flow Meter segment holds the major share”

Based on Diagnostic devices, the market is fragmented into Spirometers, Polysomnography (PSG) Devices, Peak Flow Meters, and Other Diagnostic Devices. Peak flow Meter devices are expected to dominate the market in the upcoming period owing to their lightweight, easy to handle, and portable. Furthermore, these devices can be connected remotely for the diagnosis of respiration rate. For instance, “The Microlife PF 100” is a digital measuring device for the detection of peak expiratory flow (PEF) as well as forced expiratory volume for the monitoring of respiration rate in asthmatic patients.

Amongst Indication, the Asthma segment holds the major share”

Based on Indication, the market is segmented into Asthma and COPD. The Asthma sub-segment is expected to dominate the market owing to the rise in outdoor and indoor causative agents such as allergens, dust, and pollution. As per World Health Organization (2019), Asthma affected an estimated 262 million people in 2019 and caused 461000 deaths, worldwide.

Amongst End-user, the Homecare segment holds the major share”

Based on End-user, the market is fragmented into Homecare, Hospitals, Clinics, and Other end-users. Hospital sub-segment is expected to dominate the market owing to an increase in the number of patients suffering from respiratory diseases, a rise in government initiatives, and advancements In technology in terms of COPD and asthma devices.

“North America signifies one of the largest markets and Europe is expected to be the fastest-growing markets of COPD and Asthma Diagnostic and Monitoring Devices Market.”

For a better understanding of the market dynamics of the COPD and Asthma Diagnostic and Monitoring Devices Market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the government support for advanced research and development in the field of COPD and Asthma devices and increasing awareness regarding the benefits offered by these devices.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

COPD and Asthma Diagnostic and Monitoring Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

  1.1Market Definitions
  1.2Limitations
  1.3Stake Holders
  1.4Currency Used in Report

 

  2.1Research Process of the COPD and Asthma Diagnostic and Monitoring Devices  Market
  2.2Research Methodology of the COPD and Asthma Diagnostic and Monitoring Devices  Market
  2.3Forecasting Method
  2.4Respondent Profile
  2.5Main Objective of the COPD and Asthma Diagnostic and Monitoring Devices Market Study

 

  6.1Ventilator 
  6.2Mask 
  6.3PAP (Positive Airway Pressure) Device
  6.4Inhaler 
  6.5Nebulizer

 

  7.1Pulse Oximeters
  7.2Capnographs
  7.3Gas Analysers

 

  8.1Spirometers
  8.2Polysomnography (PSG) Devices
  8.3Peak Flow Meters
  8.4Other Diagnostic Devices

 

  9.1Asthma 
  9.2COPD

 

  10.1Homecare
  10.2Hospitals  
  10.3Clinics   
  10.4Other end-users 

 

  11.1NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET 
   11.1.1United States
   11.1.2Canada
   11.1.3Rest of North America
  11.2EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET 
   11.2.1Germany
   11.2.2France
   11.2.3United Kingdom
   11.2.4Italy
   11.2.5Spain
   11.2.6Rest of Europe
  11.3ASIA PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
   11.3.1China
   11.3.2Japan
   11.3.3India
   11.3.4Australia
   11.3.5Rest of Asia Pacific
  11.4REST OF WORLD COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET

 

  12.1Demand Side Analysis
  12.2Supply Side Analysis
   12.1.1Top Product Launches
   12.1.2Top Business Partnerships
   12.1.3Top Business Exapnsions, Investments and Diverstitures
   12.1.4Top Merger and Acquisitions 
  15.1Drivers 
  15.2Challenges
  15.3Impact Analysis

 

  18.1Drägerwerk AG & CO  KGAA
  18.2Getinge AB
  18.3Invacare Corporation
  18.4Masimo Corporation 
  18.5Vyaire Medical Inc
  18.6Koninklijke Philips NV
  18.7Becton Dickinson And Company
  18.8Nihon Kohden Corporation
  18.9Smiths Medical
  18.10Medtronic plc

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global COPD and Asthma Diagnostic and Monitoring Devices Market were the three major steps undertaken to create and analyze the adoption of COPD and Asthma Diagnostic and Monitoring Devices for the different applications across major sectors such as Healthcare Providers, Homecare, and Hospitals globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the COPD and Asthma Diagnostic and Monitoring Devices sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the COPD and Asthma Diagnostic and Monitoring Devices through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the COPD and Asthma Diagnostic and Monitoring Devices market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are Connected sensors, Integrated Connected Devices, Technology, and End-user. Further country-level analyses were conducted to evaluate the overall adoption of COPD and Asthma Diagnostic and Monitoring Devices in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Connected Drug Delivery Devices. Further, we conducted factor analysis using dependent and independent variables such as rising incidence of Asthma and COPD cases, rise in the aging population, rising prevalence of tobacco smoking, increase in Urbanization and pollution, increase in the preterm birth cases, lifestyle changes, and increase in Government initiatives

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the COPD and Asthma Diagnostic and Monitoring Devices Market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (USD) and the adoption rate of COPD and Asthma Diagnostic and Monitoring Devices across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the COPD and Asthma Diagnostic and Monitoring Devices market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the COPD and Asthma Diagnostic and Monitoring Devices market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of therapeutic devices, monitoring devices, diagnostic devices, Indication, End-user, and Region of the COPD and Asthma Diagnostic and Monitoring Devices market.

Main Objective of the COPD and Asthma Diagnostic and Monitoring Devices Market Study

The current & future market trends of COPD and Asthma Diagnostic and Monitoring Devices were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of COPD and Asthma Diagnostic and Monitoring Devices in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of therapeutic devices, monitoring devices, diagnostic devices, Indication, End-user, and Region.
  • Define and analysis of the regulatory framework for the COPD and Asthma Diagnostic and Monitoring Devices industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the COPD and Asthma Diagnostic and Monitoring Devices market for the major region
  • Major regions studied in the report include North America (the United States and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India, and Australia), and Rest of the World
  • Company profiles of the COPD and Asthma Diagnostic and Monitoring Devices market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry